Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$19.3M Buy
255,921
+140,976
+123% +$10.6M 0.27% 74
2025
Q4
$8.56M Buy
114,945
+112,281
+4,215% +$8.2M 0.12% 114
2025
Q3
$180K Buy
2,664
+102
+4% +$6.77K ﹤0.01% 424
2025
Q2
$166K Buy
2,562
+329
+15% +$19.7K ﹤0.01% 376
2025
Q1
$139K Sell
2,233
-184
-8% -$12.2K ﹤0.01% 375
2024
Q4
$174K Buy
+2,417
New +$189K ﹤0.01% 284

Other funds holding HOLX

Groupe la Francaise's HOLX Position: Q1 2026 in Review

Groupe la Francaise increased its Hologic (HOLX) stake by 123% in Q1 2026, buying an estimated $10.6M and bringing the position to 255,921 shares worth $19.3M. The position accounts for 0.27% of the portfolio, ranked #74.

Groupe la Francaise first reported a position in HOLX in Q4 2024 and has held it in 6 quarters since. 704 funds tracked by Wall St. Rank hold HOLX as of Q1 2026.

  • Groupe la Francaise held 255,921 shares of Hologic worth $19.3M as of Q1 2026.
  • Groupe la Francaise bought 140,976 Hologic shares in Q1 2026, an estimated $10.6M.
  • Hologic made up 0.27% of Groupe la Francaise's portfolio in Q1 2026, its #74 holding.
  • Groupe la Francaise first reported a position in Hologic in Q4 2024 and has held it in 6 quarters since.
  • 704 funds tracked by Wall St. Rank held Hologic as of Q1 2026.

Based on Groupe la Francaise's 13F filing for Q1 2026, filed 21 May 2026.